Paragraph 10 F1
A cannabis-based product for medicinal use in humans.
A product which is—
specified in Part 1 as a consequence of the application of paragraphs 2 to 5 to a preparation or other product (not being the substance specified in paragraph 9) which is or contains cannabis, cannabis resin, cannabinol or a cannabinol derivative (not being dronabinol or its stereoisomers); and
produced for medicinal use in humans.
In this paragraph—
“cannabis-based product for medicinal use in humans” means a preparation or other product (not being the substance specified in paragraph 9), which—
- (a)
is or contains cannabis, cannabis resin, cannabinol or a cannabinol derivative (not being dronabinol or its stereoisomers);
- (b)
is produced for medicinal use in humans; and
- (c)
is—
- (i)
a medicinal product, or
- (ii)
a substance or preparation for use as an ingredient of, or in the production of an ingredient of, a medicinal product; and
- (i)
- (a)
“medicinal product” has the same meaning as in the Human Medicines Regulations 2012.
In this Schedule, “dronabinol” does not include any substance which—
has the international non-proprietary name dronabinol (recommended by the World Health Organisation); and
is derived from cannabis, cannabis resin or their constituents,
and stereoisomers of dronabinol are to be construed accordingly.